August, 2011 - SUPPORT Summary of a systematic review | print this article |
The role of pharmacists includes dispensing medication, and the packaging and compounding of prescriptions. But over the last two decades these responsibilities have expanded to include ensuring the proper use of medication as well as identifying, preventing and resolving drug-related problems. Pharmacists also promote health services and provide educational information.
Pharmacists play an important role in providing and interpreting information related to self-medication and self-care. As these practices become more popular, the role of pharmacists in community pharmacies that offer patient care is likely to be enhanced. Increased demands for healthcare, the complex and expanding range of available medicines, the greater use of prescribed medications, and poor patient adherence, are all factors that have contributed to pharmacists needing to deliver patient-targeted services. These services include ensuring that medicines are correctly used, as well as the identification, prevention and resolution of drug-related problems (such as side effects or adverse effects). Pharmacists also contribute to the provision of health promotion services (including screening services for chronic diseases) and provide educational information.
Review Objectives:To examine the effectiveness of services provided by pharmacists on patient outcomes and health service utilisation and costs in low- and middle-income countries |
||
/ | What the review authors searched for | What the review authors found |
---|---|---|
Interventions |
Any health or drug-related patient-targeted services delivered by pharmacists (other than drug compounding and dispensing, and excluding other services such as the selling of cosmetics or other non-pharmaceutical products) evaluated in a randomised trial, non-randomised trial, controlled before-and-after study, or interrupted time series analysis. |
12 randomised trials in middle-income countries were included. 11 examined pharmacist interventions targeted at patients, and 1 evaluated a pharmacist intervention targeted at healthcare professionals. All the studies included compared pharmacist-provided services with usual care. |
Participants |
Pharmacists (or pharmacies) delivering services in outpatient settings other than, or in addition to, drug compounding and dispensing. Studies of pharmacists delivering services to outpatients in a clinic attached to a hospital or a day hospital were included in the review. |
In all the studies, interventions were performed either by practising pharmacists or research pharmacists. 11 studies were randomised by patients, while 1 study was randomised by general practices. 5 of these 11 studies were conducted in the outpatient department of hospitals, 5 studies were conducted in community pharmacies, and 2 in primary health centres (1 was outpatient and primary care centre). |
Settings |
Outpatient settings |
Sudan (1), India (2), Egypt (1), Paraguay (1), Thai-land (2), Chile (2), Bulgaria (2), and South Africa (1). |
Outcomes |
Objective measurement of patient outcomes and process outcomes such as health service utilisation and costs. |
Objective measurement of patient outcomes and process outcomes such as health service utilisation and costs. Objective measurement of patient outcomes and process outcomes such as health service utilisation and costs. |
Date of most recent search: March 2010 | ||
Limitations: This is a good quality systematic review with minor limitations. There were few evaluations of impact that allowed robust conclusions to be drawn, particularly as many of the studies did not take all the costs involved into account. |
Pande S. A systematic review of the effectiveness of pharmacist provided services on patient outcomes, health-service utilisation and costs in low- and middle-income countries. MPH Dissertation University of Adelaide, Australia, 2010.
Twelve studies were eligible for this review. Of these, 11 examined pharmacist interventions targeted at patients, and 1 evaluated a pharmacist intervention targeted at healthcare professionals. Seven studies were undertaken in low- and middle-income countries (Sudan, 1; India, 2; Egypt, 1; Paraguay, 1; Thailand, 2); and 5 in upper middle-income countries (Chile, 2; Bulgaria, 2; South Africa, 1). None of the studies presented data on total costs. One study presented data on medication costs. All the studies provided data on patient outcomes and 4 studies examined health service utilisation.
11 of the 12 studies compared pharmacist-provided services with usual care. Interventions included patient education and counselling (11), complete pharmaceutical care follow-up (3), and bespoke educational booklets explaining disease, medication and lifestyle modifications (7). The duration of the interventions ranged between 20-50 minutes, and 3 of the 11 interventions were conducted over periods ranging between 9 weeks and 6 months.
Patient or population: Pharmacists (or pharmacies) delivering services in outpatient settings |
|||||
Outcomes | Impact | No of Participants (studies) |
Quality of the evidence (GRADE) |
||
Health service utilisation |
Rate of hospitalisation, general practice and emergency visits can probably be reduced. In one study, for example, the reduction in general practice visits was 14% for the intervention group and 0% for the control group. |
590 patients (4 studies) |
|
||
Medication costs |
Medication costs of patients with asthma and chronic obstructive pulmonary disease may decrease. Other costs were not reported. |
350 patients |
|||
Clinical outcomes | Clinical outcomes* for diabetic and hypertensive patients may improve; e.g. reduction in fasting plasma glucose levels or systolic and diastolic blood pressure. |
1,102 |
|||
p: p-value GRADE: GRADE Working Group grades of evidence (see above and last page) |
1 of the 12 studies evaluated this comparison. The main aim of this study was to improve the diagnosis, prescribing and follow-up care provided by general practitioners to children with asthma. The intervention was educational outreach. This study reported an improvement in the asthma score in the intervention group compared to the control group.
Patient or population: Pharmacists delivering educational outreach visits to general practitioners |
|||
Outcomes | Impact | No of Participants (studies) |
Quality of the evidence (GRADE) |
Patient outcome |
There was an improvement on asthma scores as reported by the parents or guardians of children that were cared for by general practitioners in the educational outreach group. |
43 general practitioners and 318 patients (1 study) |
|
p: p-value GRADE: GRADE Working Group grades of evidence (see above and last page) |
Findings | Interpretation* |
---|---|
APPLICABILITY | |
|
|
EQUITY | |
|
|
ECONOMIC CONSIDERATIONS | |
|
Insufficient information was provided to allow for the assessment of the costs or savings associated with services provided by pharmacists. These costs might include training costs of pharmacists, medication costs, costs of healthcare professional fees, and transport costs for patients. |
MONITORING & EVALUATION | |
|
|
*Judgements made by the authors of this summary, not necessarily those of the review authors, based on the findings of the review and consultation with researchers and policymakers in low and middle-income countries. For additional details about how these judgements were made see: http://supportsummaries.org/support-summaries/how-support-summaries-are-prepared/ |
Related literature
Beney, J, Bero, L & Bond, C 2000, ‘Expanding the roles of outpatient pharma-cists: effects on health services utilisation, costs, and patient outcomes’, Cochrane Database Syst Rev, no. 3, p. CD000336.
Roughead EE, Semple SJ, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes. International Journal of Pharmacy Practice.2005;13(1):53-70.
This summary was prepared by
Fatima Suleman, University of KwaZulu-Natal, South Africa
Conflict of interest
None declared. For details, see: Conflicts of interest
Acknowledgements
This summary has been peer reviewed by: Elizeus Rutebemberwa, Uganda; Sami Pande, Australia
This summary should be cited as
Suleman F. Do additional services provided by pharmacists reduce healthcare costs or the demand for healthcare in low- and middle-income countries? A SUPPORT Summary of a systematic review. August 2011